Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease

The Lancet Neurology

Volumn 10, Issue 2, 2011, Pages 187-198

  Kapogiannis, Dimitrios ^a   Mattson, Mark P ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPHIC FACTOR;

ALZHEIMER DISEASE; BRAIN METABOLISM; CALORIC INTAKE; CELL ENERGY; COGNITIVE DEFECT; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; HISTOPATHOLOGY; HUMAN; METABOLIC STRESS; NERVE CELL; NERVE DEGENERATION; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; SYNAPTIC POTENTIAL;

ALZHEIMER DISEASE; ANIMALS; BRAIN; COGNITION DISORDERS; ENERGY METABOLISM; HUMANS; NERVE NET;

EID: 78751566697     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70277-5     Document Type: Note

References (138)

1. Gunstad J, Lhotsky A, Wendell CR, et al. Longitudinal examination of obesity and cognitive function: results from the Baltimore Longitudinal Study of Aging. Neuroepidemiology 2010, 34:222-229.
2. Luchsinger JA, Reitz C, Patel B, et al. Relation of diabetes to mild cognitive impairment. Arch Neurol 2007, 64:570-575.
3. Toro P, Schonknecht P, Schroder J Type II diabetes in mild cognitive impairment and Alzheimer's disease: results from a prospective population-based study in Germany. J Alzheimers Dis 2009, 16:687-691.
4. Sperling RA, Dickerson BC, Pihlajamaki M, et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010, 12:27-43.
5. Fouquet M, Desgranges B, Landeau B, et al. Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease. Brain 2009, 132:2058-2067.
6. Blalock EM, Grondin R, Chen KC, et al. Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys. J Neurosci 2010, 30:6058-6071.
7. Dumont M, Ho DJ, Calingasan NY, et al. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. Free Radic Biol Med 2009, 47:1019-1027.
8. Quick KL, Ali SS, Arch R, et al. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging 2008, 29:117-128.
9. Winocur G, Greenwood CE The effects of high fat diets and environmental influences on cognitive performance in rats. Behav Brain Res 1999, 101:153-161.
10. Mielke JG, Nicolitch K, Avellaneda V, et al. Longitudinal study of the effects of a high-fat diet on glucose regulation, hippocampal function, and cerebral insulin sensitivity in C57BL/6 mice. Behav Brain Res 2006, 175:374-382.
11. Stranahan AM, Arumugam TV, Cutler RG, et al. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
12. Geda YE, Roberts RO, Knopman DS, et al. Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol 67: 80-86.
13. Etgen T, Sander D, Huntgeburth U, et al. Physical activity and incident cognitive impairment in elderly persons: the INVADE study. Arch Intern Med 170: 186-93.
14. Baker LD, Frank LL, Foster-Schubert K, et al. Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol 67: 71-79.
15. Lautenschlager NT, Cox KL, Flicker L, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA 2008, 300:1027-1037.
16. Erickson KI, Prakash RS, Voss MW, et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 2009, 19:1030-1039.
17. Colcombe SJ, Erickson KI, Scalf PE, et al. Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 2006, 61:1166-1170.
18. Nichol K, Deeny SP, Seif J, et al. Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement 2009, 5:287-294.
19. Kannangara TS, Lucero MJ, Gil-Mohapel J, et al. Running reduces stress and enhances cell genesis in aged mice. Neurobiol Aging 2010, published online Jan 27. 10.1016/j.neurobiolaging.2009.12.025.
20. Ding Q, Vaynman S, Souda P, et al. Exercise affects energy metabolism and neural plasticity-related proteins in the hippocampus as revealed by proteomic analysis. Eur J Neurosci 2006, 24:1265-1276.
21. Mesulam M Representation, inference, and transcendent encoding in neurocognitive networks of the human brain. Annals Neurol 2008, 64:367-378.
22. He Y, Wang J, Wang L, et al. Uncovering intrinsic modular organization of spontaneous brain activity in humans. PLoS One 2009, 4:e5226.
23. Achard S, Bullmore E Efficiency and cost of economical brain functional networks. PLoS Comput Biol 2007, 3:e17.
24. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991, 1:103-116.
25. Seeley WW, Crawford RK, Zhou J, et al. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009, 62:42-52.
26. Buckner RL, Sepulcre J, Talukdar T, et al. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 2009, 29:1860-1873.
27. Jack CR, Lowe VJ, Weigand SD, et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
28. Cohen AD, Price JC, Weissfeld LA, et al. Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci 2009, 29:14770-14778.
29. Dickerson BC, Bakkour A, Salat DH, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009, 19:497-510.
30. Mosconi L, Mistur R, Switalski R, et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 2009, 36:811-822.
31. Johnson DK, Storandt M, Morris JC, et al. Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol 2009, 66:1254-1259.
32. Braak H, Braak E Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
33. Wegiel J, Bobinski M, Tarnawski M, et al. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration. Acta Neuropathol 2001, 101:585-590.
34. Thal DR, Rub U, Orantes M, et al. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
35. Hyman BT, Van Hoesen GW, Damasio AR, et al. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984, 225:1168-1170.
36. Remondes M, Schuman EM Direct cortical input modulates plasticity and spiking in CA1 pyramidal neurons. Nature 2002, 416:736-740.
37. Scheff SW, Price DA Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis 2006, 9:101-115.
38. Seeley WW, Allman JM, Carlin DA, et al. Divergent social functioning in behavioral variant frontotemporal dementia and Alzheimer disease: reciprocal networks and neuronal evolution. Alzheimer Dis Assoc Disord 2007, 21:S50-S57.
39. Braak H, Braak E Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol 1991, 81:261-268.
40. Gong Y, Chang L, Viola KL, et al. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 2003, 100:10417-10422.
41. Palop JJ, Chin J, Roberson ED, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55:697-711.
42. Busche MA, Eichhoff G, Adelsberger H, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321:1686-1689.
43. Kamenetz F, Tomita T, Hsieh H, et al. APP processing and synaptic function. Neuron 2003, 37:925-937.
44. Li S, Hong S, Shepardson NE, et al. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
45. Selkoe DJ Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 2008, 192:106-113.
46. Mattson MP Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
47. LaManna JC, Harik SI Regional comparisons of brain glucose influx. Brain Res 1985, 326:299-305.
48. Rowe WB, Blalock EM, Chen KC, et al. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci 2007, 27:3098-3110.
49. Wu W, Brickman AM, Luchsinger J, et al. The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Annals Neurol 2008, 64:698-706.
50. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005, 25:7709-7717.
51. Hedden T, Van Dijk KR, Becker JA, et al. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J Neurosci 2009, 29:12686-12694.
52. Sperling RA, LaViolette PS, O'Keefe K, et al. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009, 63:178-188.
53. Miller SL, Celone K, DePeau K, et al. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci USA 2008, 105:2181-2186.
54. Woodard JL, Seidenberg M, Nielson KA, et al. Semantic memory activation in amnestic mild cognitive impairment. Brain 2009, 132:2068-2078.
55. Nielson KA, Douville KL, Seidenberg M, et al. Age-related functional recruitment for famous name recognition: an event-related fMRI study. Neurobiol Aging 2006, 27:1494-1504.
56. Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci 2006, 26:10222-10231.
57. Kann O, Kovacs R Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007, 292:C641-C657.
58. Reis HJ, Guatimosim C, Paquet M, et al. Neuro-transmitters in the central nervous system & their implication in learning and memory processes. Curr Med Chem 2009, 16:796-840.
59. Tampellini D, Rahman N, Gallo EF, et al. Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci 2009, 29:9704-9713.
60. Maubach K GABA(A) receptor subtype selective cognition enhancers. Curr Drug Targets CNS Neurol Disord 2003, 2:233-239.
61. Mattson MP Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med 2003, 3:65-94.
62. Vela J, Gutierrez A, Vitorica J, et al. Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J Neurochem 2003, 85:368-377.
63. Armanini MP, Hutchins C, Stein BA, et al. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res 1990, 532:7-12.
64. Mattson MP, Cheng B, Davis D, et al. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992, 12:376-389.
65. Larner AJ Epileptic seizures in AD patients. Neuromolecular Med 2010, 12:71-77.
66. Hu NW, Klyubin I, Anwy R, et al. GluN2B subunit-containing NMDA receptor antagonists prevent Abeta-mediated synaptic plasticity disruption in vivo. Proc Natl Acad Sci USA 2009, 106:20504-20509.
67. Sepulveda FJ, Opazo C, Aguayo LG Alzheimer beta-amyloid blocks epileptiform activity in hippocampal neurons. Mol Cell Neurosci 2009, 41:420-428.
68. Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
69. Loerch PM, Lu T, Dakin KA, et al. Evolution of the aging brain transcriptome and synaptic regulation. PLoS One 2008, 3:e3329.
70. Reddy PH, McWeeney S, Park BS, et al. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 2004, 13:1225-1240.
71. Gleichmann M, Zhang Y, Wood WH, et al. Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks. Neurobiol Aging 2010, published online Oct 13. 10.1016/j.neurobiolaging.2010.08.012.
72. Xu X, Zhan M, Duan W, et al. Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome Biol 2007, 8:R234.
73. Yang JL, Tadokoro T, Keijzers G, et al. Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. J Biol Chem 2010, 285:28191-28199.
74. Bingol B, Schuman EM Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 2006, 441:1144-1148.
75. Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H When neurogenesis encounters aging and disease. Trends Neurosci 2010, 33:569-579.
76. Burkhalter J, Fiumelli H, Allaman I, et al. Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J Neurosci 2003, 23:8212-8220.
77. Peng S, Garzon DJ, Marchese M, et al. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J Neurosci 2009, 29:9321-9329.
78. Tong L, Balazs R, Thornton PL, et al. Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci 2004, 24:6799-6809.
79. Poon WW, Blurton-Jones M, Tu CH, et al. beta-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiol Aging 2009, published online June 21. 10.1016/j.neurobiolaging.2009.05.012.
80. Li G, Peskind ER, Millard SP, et al. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 2009, 4:e5424.
81. Mark RJ, Pang Z, Geddes JW, et al. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 1997, 17:1046-1054.
82. Mattson MP ER calcium and Alzheimer's disease: in a state of flux. Sci Signal 2010, 3:pe10.
83. Mattson MP, Gleichmann M, Cheng A Mitochondria in neuroplasticity and neurological disorders. Neuron 2008, 60:748-766.
84. Bubber P, Haroutunian V, Fisch G, et al. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Annals Neurol 2005, 57:695-703.
85. Li Z, Okamoto K, Hayashi Y, et al. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
86. Shukkur EA, Shimohata A, Akagi T, et al. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome. Hum Mol Genet 2006, 15:2752-2762.
87. Muyllaert D, Kremer A, Jaworski T, et al. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?. Genes Brain Behav 2008, 7(suppl 1):57-66.
88. Martinez A, Perez DI GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer's disease?. J Alzheimers Dis 2008, 15:181-191.
89. Sereno L, Coma M, Rodriguez M, et al. A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis 2009, 35:359-367.
90. Buller CL, Loberg RD, Fan MH, et al. A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol 2008, 295:C836-C843.
91. Bolos M, Fernandez S, Torres-Aleman I Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels. J Biol Chem 2010, 285:17693-17700.
92. Komatsu T, Chiba T, Yamaza H, et al. Manipulation of caloric content but not diet composition, attenuates the deficit in learning and memory of senescence-accelerated mouse strain P8. Exp Gerontol 2008, 43:339-346.
93. Ingram DK, Weindruch R, Spangler EL, et al. Dietary restriction benefits learning and motor performance of aged mice. J Gerontol 1987, 42:78-81.
94. Pitsikas N, Algeri S Deterioration of spatial and nonspatial reference and working memory in aged rats: protective effect of life-long calorie restriction. Neurobiol Aging 1992, 13:369-373.
95. Means LW, Higgins JL, Fernandez TJ Mid-life onset of dietary restriction extends life and prolongs cognitive functioning. Physiol Behav 1993, 54:503-508.
96. Cao D, Lu H, Lewis TL, et al. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007, 282:36275-36282.
97. Halagappa VK, Guo Z, Pearson M, et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2007, 26:212-220.
98. Wu P, Shen Q, Dong S, et al. Calorie restriction ameliorates neurodegenerative phenotypes in forebrain-specific presenilin-1 and presenilin-2 double knockout mice. Neurobiol Aging 2008, 29:1502-1511.
99. Bruce-Keller AJ, White CL, Gupta S, et al. NOX activity in brain aging: exacerbation by high fat diet. Free Radic Biol Med 2010, 49:22-30.
100. Hyun DH, Emerson SS, Jo DG, et al. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci USA 2006, 103:19908-19912.
101. Pistell PJ, Morrison CD, Gupta S, et al. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 2010, 219:25-32.
102. Guo Z, Ersoz A, Butterfield DA, et al. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J Neurochem 2000, 75:314-320.
103. Arumugam TV, Phillips TM, Cheng A, et al. Age and energy intake interact to modify cell stress pathways and stroke outcome. Annals Neurol 2010, 67:41-52.
104. van Praag H Exercise and the brain: something to chew on. Trends Neurosci 2009, 32:283-290.
105. Gray J, Yeo GS, Cox JJ, et al. Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006, 55:3366-3371.
106. Yeo GS, Hung CC Connie, Rochford J, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 2004, 7:1187-1189.
107. Bishop NA, Lu T, Yankner BA Neural mechanisms of ageing and cognitive decline. Nature 2010, 464:529-535.
108. Takeda S, Sato N, Uchio-Yamada K, et al. Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA 2010, 107:7036-7041.
109. Stranahan AM, Lee K, Becker KG, et al. Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiol Aging 2008, 31:1937-1949.
110. Wolf SA, Kronenberg G, Lehmann K, et al. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease. Biol Psychiatry 2006, 60:1314-1323.
111. Vaynman S, Ying Z, Gomez-Pinilla F Hippocampal BDNF mediates the efficacy of exercise on synaptic plasticity and cognition. Eur J Neurosci 2004, 20:2580-2590.
112. Stranahan AM, Lee K, Martin B, et al. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009, 19:951-961.
113. Berchtold NC, Castello N, Cotman CW Exercise and time-dependent benefits to learning and memory. Neuroscience 2010, 167:588-597.
114. Llorens-Martin M, Torres-Aleman I, Trejo JL Mechanisms mediating brain plasticity: IGF1 and adult hippocampal neurogenesis. Neuroscientist 2009, 15:134-148.
115. Shen H, Tong L, Balazs R, et al. Physical activity elicits sustained activation of the cyclic AMP response element-binding protein and mitogen-activated protein kinase in the rat hippocampus. Neuroscience 2001, 107:219-229.
116. Li Y, Duffy KB, Ottinger MA, et al. GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. J Alzheimers Dis 2010, 19:1205-1219.
117. De Felice FG, Vieira MN, Bomfim TR, et al. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci USA 2009, 106:1971-1976.
118. Plastino M, Fava A, Pirritano D, et al. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. J Neurol Sci 2010, 288:112-116.
119. Reger MA, Watson GS, Green PS, et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 2008, 70:440-448.
120. Gold M, Alderton C, Zvartau-Hind M Rosiglitazone monotherapy in mild-to-moderate alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dement Geriatr Cogn Disord 2010, 30:131-146.
121. Perry TA, Greig NH A new Alzheimer's disease interventive strategy: GLP-1. Curr Drug Targets 2004, 5:565-571.
122. Gengler S, McClean PL, McCurtin R, et al. Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiol Aging 2010, published online March 31. 10.1016/j.neurobiolaging.2010.02.014.
123. D'Amico M, Di Filippo C, Marfella R, et al. Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice. Exp Gerontol 2010, 45:202-207.
124. Exendin-4 for the treatment of Alzheimer's disease National Institute on Aging, (accessed Aug 31, 2010). http://www.alzheimers.org/clinicaltrials/fullrec.asp?PrimaryKey=377.
125. Longo FM, Yang T, Knowles JK, et al. Small molecule neurotrophin receptor ligands: novel strategies for targeting Alzheimer's disease mechanisms. Curr Alz Res 2007, 4:503-506.
126. Nagahara AH, Bernot T, Moseanko R, et al. Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery. Exp Neurol 2009, 215:153-159.
127. Wu K, Meyers CA, Guerra NK, et al. The effects of rAAV2-mediated NGF gene delivery in adult and aged rats. Mol Ther 2004, 9:262-269.
128. Capsoni S, Covaceuszach S, Ugolini G, et al. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice. J Alzheimers Dis 2009, 16:371-388.
129. Covaceuszach S, Capsoni S, Ugolini G, et al. Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr Alz Res 2009, 6:158-170.
130. Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 2009, 15:331-337.
131. Brewer GJ, Wallimann TW Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 2000, 74:1968-1978.
132. Sullivan PG, Geiger JD, Mattson MP, et al. Dietary supplement creatine protects against traumatic brain injury. Annals Neurol 2000, 48:723-729.
133. Rex A, Spychalla M, Fink H Treatment with reduced nicotinamide adenine dinucleotide (NADH) improves water maze performance in old Wistar rats. Behav Brain Res 2004, 154:149-153.
134. Green KN, Steffan JS, Martinez-Coria H, et al. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 2008, 28:11500-11510.
135. Morris MC, Evans DA, Bienias JL, et al. Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatry 2004, 75:1093-1099.
136. Liu D, Pitta M, Lee JH, et al. The KATP channel activator diazoxide ameliorates Abeta and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. J Alzheimers Dis 2010, 22:443-457.
137. Johnson JB, Summer W, Cutler RG, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med 2007, 42:665-674.
138. Bolognesi ML, Matera R, Minarini A, et al. Alzheimer's disease: new approaches to drug discovery. Curr Opin Chem Biol 2009, 13:303-308.